At CTO West Coast, an expert discussed the implications of the FDA’s expedited approval programmes with a spotlight on ...

The FDA is implementing stricter guidance for the approval of COVID-19 vaccines, according to a paper published in The New England Journal of Medicine.

The advisory committee meeting comes days after the FDA unveiled a new risk-based approval framework for COVID-19 vaccines.

The FDA will limit the vaccine’s availability later this year to older adults and those who may be at risk of severe illness.

This week, two new leaders at the US Food and Drug Administration announced plans to limit access to covid vaccines, arguing ...

Secretary Kennedy's appointment led to fears that vaccine availability would be curtailed. Those fears are now being realized.

The agency told vaccine makers that COVID-19 vaccines used in the United States starting in fall 2025 should be based on JN.1 ...